Benzinga

Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Benzinga

Premium Services
Financial News
Financial News
Large Cap Stocks
Small-Cap Stocks
Insider Trades
Earnings
Technology
AI News
Personal Finance
ETF News
Crypto News
Dividend News
Latest Rumors
Latest Offerings News
Investment Ideas
Investment Ideas
Stock of the Day
Stock Whisper Index
Analyst Ratings
Analyst Color
Financial Advisors
Government Trades
Trading Ideas
Stock Screener
Markets
Markets
Premarket Movers
After Hours
Options
ETFs
Commodities
Prediction Markets
Private Markets
Bonds
Futures
Forex
Top Stocks
Top Stocks
Apple (AAPL)
Tesla (TSLA)
Amazon (AMZN)
Nvidia (NVDA)
Alphabet (GOOGL)
Meta Platforms (META)
Microsoft (MSFT)
StreetTracks Gold Shares (GLD)
IBIT Bitcoin Trust (IBIT)
Top Value Stocks
Top Momentum Stocks
Top Growth Stocks
Top Quality Stocks
Learn
Learn
Investing Guides
Personal Finance
Mortgages
Best Credit Cards
Best Dividend Stocks
Best Swing Trade Stocks

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Unusual Options Activity Calendar

Stock Split Calendar

Trade Ideas

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Compare Best Stocks

Best Momentum Stocks

Best Quality Stocks

Best Value Stocks

Best Growth Stocks

APPILI THERAPEUTICS INC by Appili Therapeutics Inc. Stock News

APLIFOTCPK

Trade with Public

Trade with Public

$0.0161

At close: May 15, 5:00 PM EST

OverviewNewsShort Interest

Latest APPILI THERAPEUTICS INC by Appili Therapeutics Inc. Stock News | OTC:APLIF | Benzinga

Get the latest news on APPILI THERAPEUTICS INC by Appili Therapeutics Inc. stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on APPILI THERAPEUTICS INC by Appili Therapeutics Inc. performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, August 21, 2024

PRO
Aditxt's Adivir, Inc., Agreed To Acquire All ...
Benzinga Newsdesk

Thursday, July 25, 2024

PRO
Aditxt Signs Second Amendment To The Arrangem...
Benzinga Newsdesk

Tuesday, September 06, 2022

APLIF: Advancing Multiple Programs to Combat Infectious Diseases…
Zacks Small Cap Research

Thursday, July 14, 2022

APLIF: New Late Stage Program to Treat Cutaneous Leishmaniasis…
Zacks Small Cap Research

Thursday, March 03, 2022

APLIF: U.S. DoD to Provide Over US$10 Million in Funding for ATI-1701…
Zacks Small Cap Research

Tuesday, December 28, 2021

Aditxt Signs Share Exchange Agreement to Acquire AiPharma in Cash, Stock Deal
Charles Gross

Monday, November 29, 2021

APLIF: PRESECO Trial Unsuccessful in COVID-19…
Zacks Small Cap Research

Friday, November 05, 2021

A Deep Dive Into COVID Oral Treatments — What Does the Atea Failure Mean for Oral Antivirals?
Dana Salzarulo - Sponsored

Thursday, October 28, 2021

Is Pfizer Conceding Race in Hospitalized Covid Because of Todos Medical's Triple MOA Antiviral?
Dana Salzarulo - Sponsored

Tuesday, October 05, 2021

Aditxt Shares Surge On AiPharma Acquisition, Holder Of COVID-19 Candidate
Vandana Singh

Wednesday, September 01, 2021

APLIF: Awaiting Data Readout for Phase 3 PRESECO Trial in COVID-19…
Zacks Small Cap Research

Monday, June 28, 2021

APLIF: DSMB Recommends for PRESECO Trial to Complete; Data Expected in 3Q21…
Zacks Small Cap Research

Monday, May 03, 2021

Appili Pharmaceuticals ($APLIF): The Last COVID-19 Stock With Massive Upside - Under $50 Million Market Cap
Willow Research

Tuesday, November 24, 2020

PRO
Health Canada Clears Appili Therapeutics For ...
Benzinga Newsdesk

Friday, October 30, 2020

PRO
Appili Therapeutics Signs Collaboration, Deve...
Benzinga Newsdesk

Monday, August 10, 2020

FDA Clears Appili Therapeutics to Expand its Phase 2 Clinical Trial of Favipiravir for the Potential Prevention of COVID-19 at U.S. Long-Term Care Facilities
Luke J Jacobi

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investor Events
Pre-market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2026 Benzinga | All Rights Reserved